In summary, we determined that ME-CSCs regulate the inflammatory environment of cholesteatoma via TLR4-mediated NF-κB-signaling, suggesting a distinct role of ME-CSCs as drivers of cholesteatoma progression in an inflammation-dependent manner. The gene discussed is NFKB1; the disease is cholesteatoma.